- Previous Close
14.80 - Open
14.90 - Bid 14.40 x --
- Ask 14.50 x --
- Day's Range
14.40 - 14.90 - 52 Week Range
14.40 - 23.80 - Volume
4,052,351 - Avg. Volume
8,607,045 - Market Cap (intraday)
36.163B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
24.58 - EPS (TTM)
0.59 - Earnings Date Feb 27, 2025 - Mar 3, 2025
- Forward Dividend & Yield 0.37 (2.34%)
- Ex-Dividend Date Aug 29, 2024
- 1y Target Est
20.16
Bangkok Chain Hospital Public Company Limited, together with its subsidiaries, operates private hospitals in Thailand. It offers diagnosis, treatment, prevention, rehabilitation services for heart disease; open heart surgery to provide heart care and clinical treatment by cardiologists; and medical supports. The company also operates diagnostic imaging centers; eye centers that provide eye examination, treatment, and surgery services; cancer centers that offer services ranging from screening, diagnosis, and chemotherapy; fertility centers for infertility treatment, as well as diabetic wound treatment centers. In addition, the company sells health-related drinks; provides medical analysis and research services; and develops package computer programs. The company was founded in 1984 and is headquartered in Nonthaburi, Thailand.
www.bangkokchainhospital.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: BCH.BK
View MorePerformance Overview: BCH.BK
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BCH.BK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BCH.BK
View MoreValuation Measures
Market Cap
36.91B
Enterprise Value
36.59B
Trailing P/E
25.08
Forward P/E
22.08
PEG Ratio (5yr expected)
1.58
Price/Sales (ttm)
3.08
Price/Book (mrq)
2.91
Enterprise Value/Revenue
3.05
Enterprise Value/EBITDA
12.12
Financial Highlights
Profitability and Income Statement
Profit Margin
12.20%
Return on Assets (ttm)
7.18%
Return on Equity (ttm)
11.84%
Revenue (ttm)
12.01B
Net Income Avi to Common (ttm)
1.46B
Diluted EPS (ttm)
0.59
Balance Sheet and Cash Flow
Total Cash (mrq)
1.58B
Total Debt/Equity (mrq)
10.35%
Levered Free Cash Flow (ttm)
1.32B